Literature DB >> 33584639

NLRP3 Inflammasome and Its Critical Role in Gynecological Disorders and Obstetrical Complications.

Xuhui Fang1, Yanshi Wang1, Yu Zhang1, Yelin Li1, Joanne Kwak-Kim2,3, Li Wu1.   

Abstract

Inflammasomes, intracellular, multimeric protein complexes, are assembled when damage signals stimulate nucleotide-binding oligomerization domain receptors (NLRs). Several inflammasomes have been reported, including the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3), NLRP1, NLRP7, ice protease-activating factor (IPAF), absent in melanoma 2 (AIM2) and NLR family CARD domain-containing protein 4 (NLRC4). Among these inflammasomes, the NLRP3 inflammasome is the most well-studied in terms of structure and function. Unlike other inflammasomes that can only be activated by a finite number of pathogenic microorganisms, the NLRP3 inflammasome can be activated by the imbalance of the internal environment and a large number of metabolites. The biochemical function of NLRP3 inflammasome is to activate cysteine-requiring aspartate proteinase-1 (caspase-1), which converts pro-IL-1β and pro-IL-18 into their active forms, namely, IL-1β and IL-18, which are then released into the extracellular space. The well-established, classic role of NLRP3 inflammasome has been implicated in many disorders. In this review, we discuss the current understanding of NLRP3 inflammasome and its critical role in gynecological disorders and obstetrical complications.
Copyright © 2021 Fang, Wang, Zhang, Li, Kwak-kim and Wu.

Entities:  

Keywords:  IL-1β; and pyrin domain-containing protein 3 (NLRP3); cervical cancer; leucine-rich repeats-; nuclear factor kappa-B (NF-κB); nucleotide-binding oligomerization domain-containing protein-; preterm birth; recurrent pregnancy loss

Mesh:

Substances:

Year:  2021        PMID: 33584639      PMCID: PMC7876052          DOI: 10.3389/fimmu.2020.555826

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  122 in total

Review 1.  Function of Nod-like receptors in microbial recognition and host defense.

Authors:  Luigi Franchi; Neil Warner; Kyle Viani; Gabriel Nuñez
Journal:  Immunol Rev       Date:  2009-01       Impact factor: 12.988

2.  Maternal extracellular vesicles and platelets promote preeclampsia via inflammasome activation in trophoblasts.

Authors:  Shrey Kohli; Satish Ranjan; Juliane Hoffmann; Muhammed Kashif; Evelyn A Daniel; Moh'd Mohanad Al-Dabet; Fabian Bock; Sumra Nazir; Hanna Huebner; Peter R Mertens; Klaus-Dieter Fischer; Ana C Zenclussen; Stefan Offermanns; Anat Aharon; Benjamin Brenner; Khurrum Shahzad; Matthias Ruebner; Berend Isermann
Journal:  Blood       Date:  2016-09-02       Impact factor: 22.113

3.  No evidence for mutations in NLRP7, NLRP2 or KHDC3L in women with unexplained recurrent pregnancy loss or infertility.

Authors:  L Aghajanova; S Mahadevan; S Altmäe; A Stavreus-Evers; L Regan; N Sebire; P Dixon; R A Fisher; I B Van den Veyver
Journal:  Hum Reprod       Date:  2014-11-05       Impact factor: 6.918

4.  Global, regional, and national causes of child mortality in 2008: a systematic analysis.

Authors:  Robert E Black; Simon Cousens; Hope L Johnson; Joy E Lawn; Igor Rudan; Diego G Bassani; Prabhat Jha; Harry Campbell; Christa Fischer Walker; Richard Cibulskis; Thomas Eisele; Li Liu; Colin Mathers
Journal:  Lancet       Date:  2010-05-11       Impact factor: 79.321

5.  The dual role of calcium as messenger and stressor in cell damage, death, and survival.

Authors:  Claudia Cerella; Marc Diederich; Lina Ghibelli
Journal:  Int J Cell Biol       Date:  2010-03-15

Review 6.  Molecular mechanisms of inflammasome signaling.

Authors:  Anukriti Mathur; Jenni A Hayward; Si Ming Man
Journal:  J Leukoc Biol       Date:  2017-12-29       Impact factor: 4.962

7.  The evaluation of cord blood interleukin-1β levels in normal and caesarean deliveries.

Authors:  A Gedikbaşi; Ö Salihoğlu; A Çankaya; V Arica; Ch Akkuş; S Hatipoğlu; L Yaşar
Journal:  Hum Exp Toxicol       Date:  2014-02-17       Impact factor: 2.903

8.  NLRP3 inflammasome inactivation driven by miR‑223‑3p reduces tumor growth and increases anticancer immunity in breast cancer.

Authors:  Liping Zhang; Hongzhi Li; Yuwei Zang; Feng Wang
Journal:  Mol Med Rep       Date:  2019-01-23       Impact factor: 2.952

9.  Cerebral ischemia initiates an immediate innate immune response in neonates during cardiac surgery.

Authors:  Selma O Algra; Kathelijne M Groeneveld; Alvin W L Schadenberg; Felix Haas; Fabiola C M Evens; Jenny Meerding; Leo Koenderman; Nicolaas J G Jansen; Berent J Prakken
Journal:  J Neuroinflammation       Date:  2013-02-07       Impact factor: 8.322

Review 10.  Pharmacological Inhibitors of the NLRP3 Inflammasome.

Authors:  Ayesha Zahid; Bofeng Li; Arnaud John Kombe Kombe; Tengchuan Jin; Jinhui Tao
Journal:  Front Immunol       Date:  2019-10-25       Impact factor: 7.561

View more
  3 in total

1.  NLRP3 inflammasome activation in gestational diabetes mellitus placentas is associated with hydrogen sulfide synthetase deficiency.

Authors:  Wei Wu; Qing-Ying Tan; Fang-Fang Xi; Yun Ruan; Jing Wang; Qiong Luo; Xiao-Bing Dou; Tian-Xiao Hu
Journal:  Exp Ther Med       Date:  2021-11-30       Impact factor: 2.447

2.  Correlation of Serum C-Peptide, Soluble Intercellular Adhesion Molecule-1, and NLRP3 Inflammasome-Related Inflammatory Factor Interleukin-1β after Brain Magnetic Resonance Imaging Examination with Cerebral Small Vessel Disease.

Authors:  Chunli Ma; Lei Yang; Lihua Wang
Journal:  Contrast Media Mol Imaging       Date:  2022-01-27       Impact factor: 3.161

3.  NLRP3 inflammasome: A joint, potential therapeutic target in management of COVID-19 and fertility problems.

Authors:  Mahshid Bazrafkan; Elham Hosseini; Mahboobeh Nazari; Christiani Andrade Amorim; Mohammad Reza Sadeghi
Journal:  J Reprod Immunol       Date:  2021-09-21       Impact factor: 4.054

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.